Inventor · disambiguated record
Claude Wildmann
Also filed as: WILDMANN CLAUDE
5 granted patents·1 pending application·6 citations·filing 1995–2002
73Inventor score
Files withLUDWIG INST CANCER RES5
Top patents by PatentIndex Score
6 records- 0156US2003138854A1Method for determining BAGE expressionFiled 2002·Application pending·0 cites
- 0244US6465184B1Isolated nucleic acid molecule encoding peptides which form complexes with MHC molecules HLA-Cw*1601 and uses thereofLUDWIG INST CANCER RES·Filed 1999·Granted Oct 15, 2002·2 cites·7 claims
- 0343US6680056B1Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of hla-cw 1601/mage-1 derived peptides, and methods for treating said individualsLUDWIG INST CANCER RES·Filed 2000·Granted Jan 20, 2004·0 cites·3 claims
- 0439US6638512B1Method for treating subjects by using BAGE tumor rejection antigen precursors or tumor rejection antigensLUDWIG INST CANCER RES·Filed 1999·Granted Oct 28, 2003·1 cites·21 claims
- 0536US6110694AMethods for determining complexes of tumor rejection antigens and HLA-Cw*160/moleculesLUDWIG INST CANCER RES·Filed 1998·Granted Aug 29, 2000·2 cites·5 claims
- 0632US5877017AIsolated nucleic acid molecule encoding peptides which form complexes with MHC molecule HLA-Cw*1601 and uses thereofLUDWIG INST CANCER RES·Filed 1995·Granted Mar 2, 1999·1 cites·9 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →